| Sandoz Pharmaceuticals AG - Levetiracetam Sandoz 100 mg/ml, Lösung zum Einnehmen |
| 67229 | | 01 | | Levetiracetam Sandoz 100 mg/ml | | Lösung zum Einnehmen | | N03AX14 | | Levetiracetam | | 04.09.2019 | | |
|
| Composition |
| levetiracetamum 100 mg, natrii citras dihydricus, acidum citricum, E 218 2.5 mg, glycerolum, acesulfamum kalicum, maltitolum liquidum 300 mg, aromatica (Himbeer) cum alcohol benzylicus 0.0016 mg et propylenglycolum, aqua purificata ad solutionem pro 1 ml corresp. natrium 0.99 mg. |
| Packungsbestandteile |
| Solution (orale) | | | | | | | | Principe actif | Concentr. |
|---|
| Levetiracetame | 100 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Levetiracetame | 100 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acesulfamum Kalicum | | | | Acidum Citricum | | | | Aqua Purificata | | | | Aromatica (Himbeer) cum Alcohol Benzylicus | 0.0016 mg/ml | | | E 218 | 2.5 mg/ml | conserv. | | Glycerol | | | | Maltitolum Liquidum | 300 mg/ml | | | Natrii Citras Dihydricus | | | | Propylenglycol | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 300 ml | 46.05 | 66.50 | B | LS | Non |
|
